PortfoliosLab logoPortfoliosLab logo
JPM vs. NVS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

JPM vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in JPMorgan Chase & Co. (JPM) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, JPM achieves a 0.50% return, which is significantly lower than NVS's 14.40% return. Over the past 10 years, JPM has outperformed NVS with an annualized return of 21.02%, while NVS has yielded a comparatively lower 11.14% annualized return.


JPM

1D
2.31%
1M
6.82%
YTD
0.50%
6M
1.66%
1Y
21.89%
3Y*
34.22%
5Y*
17.82%
10Y*
21.02%

NVS

1D
-0.55%
1M
2.22%
YTD
14.40%
6M
18.98%
1Y
30.60%
3Y*
19.57%
5Y*
14.77%
10Y*
11.14%
*Multi-year figures are annualized to reflect compound growth (CAGR)

JPM vs. NVS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
JPM
JPMorgan Chase & Co.
0.50%37.27%44.29%30.63%-12.64%27.75%-5.53%47.26%-6.62%26.76%
NVS
Novartis AG
14.40%46.95%0.02%16.14%8.06%-3.65%3.34%13.92%5.95%19.42%

Correlation

The correlation between JPM and NVS is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.23

Correlation (10Y)
Calculated over the trailing 10-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Nov 7, 1996

0.29

The correlation between JPM and NVS shifts across timeframes, from 0.16 (3 years) to 0.29 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

JPM:

$896.00B

NVS:

$293.28B

EPS

JPM:

$21.08

NVS:

$6.99

PE Ratio

JPM:

15.21

NVS:

21.90

PEG Ratio

JPM:

1.68

NVS:

1.48

PS Ratio

JPM:

3.14

NVS:

5.29

PB Ratio

JPM:

2.60

NVS:

7.62

Total Revenue (TTM)

JPM:

$285.09B

NVS:

$56.05B

Gross Profit (TTM)

JPM:

$173.52B

NVS:

$42.19B

EBITDA (TTM)

JPM:

$81.46B

NVS:

$22.40B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

JPM vs. NVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JPM
JPM Risk / Return Rank: 6969
Overall Rank
JPM Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
JPM Sortino Ratio Rank: 6666
Sortino Ratio Rank
JPM Omega Ratio Rank: 6666
Omega Ratio Rank
JPM Calmar Ratio Rank: 7070
Calmar Ratio Rank
JPM Martin Ratio Rank: 7070
Martin Ratio Rank

NVS
NVS Risk / Return Rank: 8080
Overall Rank
NVS Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
NVS Sortino Ratio Rank: 7979
Sortino Ratio Rank
NVS Omega Ratio Rank: 7777
Omega Ratio Rank
NVS Calmar Ratio Rank: 8080
Calmar Ratio Rank
NVS Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JPM vs. NVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for JPMorgan Chase & Co. (JPM) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


JPMNVSDifference
Sharpe ratioReturn per unit of total volatility

-0.46

Sortino ratioReturn per unit of downside risk

-0.66

Omega ratioGain probability vs. loss probability

1.18

1.26

-0.07

Calmar ratioReturn relative to maximum drawdown

1.42

2.43

-1.01

Martin ratioReturn relative to average drawdown

3.36

5.88

-2.53

JPM vs. NVS - Sharpe Ratio Comparison

The current JPM Sharpe Ratio is 1.01, which is lower than the NVS Sharpe Ratio of 1.47. The chart below compares the historical Sharpe Ratios of JPM and NVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

JPM vs. NVS - Drawdown Comparison

The maximum JPM drawdown since its inception was -76.16%, which is greater than NVS's maximum drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for JPM and NVS.


Loading charts...

Drawdown Indicators


JPMNVSDifference

Max Drawdown

Largest peak-to-trough decline

-76.16%

-42.10%

-34.06%

Max Drawdown (1Y)

Largest decline over 1 year

-15.47%

-12.65%

-2.82%

Max Drawdown (3Y)

Largest decline over 3 years

-24.42%

-19.95%

-4.47%

Max Drawdown (5Y)

Largest decline over 5 years

-38.77%

-20.42%

-18.35%

Max Drawdown (10Y)

Largest decline over 10 years

-43.63%

-26.03%

-17.60%

Current Drawdown

Current decline from peak

-3.66%

-6.46%

+2.80%

Average Drawdown

Average peak-to-trough decline

-17.62%

-10.92%

-6.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.54%

5.23%

+1.31%

Volatility

JPM vs. NVS - Volatility Comparison

The current volatility for JPMorgan Chase & Co. (JPM) is 6.35%, while Novartis AG (NVS) has a volatility of 7.18%. This indicates that JPM experiences smaller price fluctuations and is considered to be less risky than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


JPMNVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.35%

7.18%

-0.83%

Volatility (6M)

Calculated over the trailing 6-month period

16.67%

14.96%

+1.71%

Volatility (1Y)

Calculated over the trailing 1-year period

21.76%

21.02%

+0.74%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.46%

18.89%

+5.57%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.39%

19.64%

+7.75%

Dividends

JPM vs. NVS - Dividend Comparison

JPM's dividend yield for the trailing twelve months is around 1.84%, less than NVS's 3.12% yield.


PositionTTM20252024202320222021202020192018201720162015
JPM
JPMorgan Chase & Co.
1.84%1.72%1.92%2.38%2.98%2.34%2.83%2.37%2.54%1.91%2.13%2.54%
NVS
Novartis AG
3.12%2.90%3.84%3.44%3.70%3.86%3.22%3.03%3.47%3.24%3.73%3.10%

Financials

JPM vs. NVS - Financials Comparison

This section allows you to compare key financial metrics between JPMorgan Chase & Co. and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B20.00B30.00B40.00B50.00B60.00B70.00B20222023202420252026
73.66B
13.52B
(JPM) Total Revenue
(NVS) Total Revenue
Values in USD except per share items

JPM vs. NVS - Profitability Comparison

The chart below illustrates the profitability comparison between JPMorgan Chase & Co. and Novartis AG over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%70.0%80.0%90.0%100.0%20222023202420252026
64.3%
74.4%
Portfolio components
JPM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, JPMorgan Chase & Co. reported a gross profit of 47.33B and revenue of 73.66B. Therefore, the gross margin over that period was 64.3%.

NVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a gross profit of 10.07B and revenue of 13.52B. Therefore, the gross margin over that period was 74.4%.

JPM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, JPMorgan Chase & Co. reported an operating income of 20.48B and revenue of 73.66B, resulting in an operating margin of 27.8%.

NVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported an operating income of 4.24B and revenue of 13.52B, resulting in an operating margin of 31.3%.

JPM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, JPMorgan Chase & Co. reported a net income of 16.49B and revenue of 73.66B, resulting in a net margin of 22.4%.

NVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a net income of 3.16B and revenue of 13.52B, resulting in a net margin of 23.3%.


Frequently Asked Questions


JPM and NVS have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NVS has higher volatility (7.18%) compared to JPM (6.35%). In terms of maximum drawdown, JPM dropped -76.16% vs NVS's -42.10%.

NVS currently has the higher Sharpe Ratio (1.47 vs 1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for JPM and NVS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer